|18th December 2020||William Jr Lehmann||20,000||Open or private sale||$2.02||$40,424.00|
|17th December 2020||John J Harrington||15,976||Payment by withholding||$1.98||$31,632.48|
|17th December 2020||Bokkelen Gil Van||26,650||Payment by withholding||$1.98||$52,767.00|
|17th December 2020||William Jr Lehmann||13,425||Payment by withholding||$1.98||$26,581.50|
|18th September 2020||William Jr Lehmann||20,000||Open or private sale||$2.04||$40,764.00|
|17th September 2020||Bokkelen Gil Van||26,656||Payment by withholding||$2.06||$54,911.36|
|17th September 2020||William Jr Lehmann||13,528||Payment by withholding||$2.06||$27,867.68|
|17th September 2020||Laura K Campbell||8,943||Payment by withholding||$2.06||$18,422.58|
|17th September 2020||John J Harrington||15,947||Payment by withholding||$2.06||$32,850.82|
|16th September 2020||John J Harrington||5,000||Open or private sale||$2.15||$10,761.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995.